Induction of terminal differentiation in cultured human keratinocytes by polychlorinated aromatic hydrocarbons as measured by cell size analysis.

[1]  L. Birnbaum,et al.  Inhibition of high-density growth arrest in human squamous carcinoma cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). , 1990, Carcinogenesis.

[2]  L. Birnbaum,et al.  Relative toxicity and tumor-promoting ability of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), 2,3,4,7,8-pentachlorodibenzofuran (PCDF), and 1,2,3,4,7,8-hexachlorodibenzofuran (HCDF) in hairless mice. , 1990, Toxicology and applied pharmacology.

[3]  S. Safe,et al.  6-Methyl-1,3,8-trichlorodibenzofuran (MCDF) as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL/6 mice. , 1989, Toxicology.

[4]  Martin van den Berg,et al.  Assessment of the toxicity of mixtures of halogenated dibenzo-p-dioxins and dibenzofurans by use of toxicity equivalency factors (TEF) , 1989 .

[5]  W. Seinen,et al.  Interactive effects of PCDD's, PCDF's and PCB's as assessed by the E.L.S.-bioassay , 1989 .

[6]  D. Phillips,et al.  Estimates of the half-life of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Vietnam Veterans of Operation Ranch Hand. , 1989, Journal of toxicology and environmental health.

[7]  S. Tanabe,et al.  Toxic potential of non-ortho and mono-ortho coplanar PCBs in commercial PCB preparations: “2,3,7,8-T4 CDD toxicity equivalence factors approach” , 1988, Bulletin of environmental contamination and toxicology.

[8]  P. Harper,et al.  Characterization of the Ah receptor and aryl hydrocarbon hydroxylase induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and benz(a)anthracene in the human A431 squamous cell carcinoma line. , 1988, Cancer research.

[9]  B. Shroot,et al.  Transglutaminases in normal and transformed human keratinocytes in culture. , 1988, The Journal of investigative dermatology.

[10]  S. M. Robinson,et al.  Identification and subcellular distribution of cornified envelope precursor proteins in the transformed human keratinocyte line SV-K14. , 1987, The Journal of investigative dermatology.

[11]  F. Korte,et al.  Bioconcentration potential of organic environmental chemicals in humans. , 1986, Regulatory toxicology and pharmacology : RTP.

[12]  L. Hudson,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) modulates epidermal growth factor (EGF) binding to basal cells from a human keratinocyte cell line. , 1986, Toxicology and applied pharmacology.

[13]  C. Schlatter,et al.  Pharmacokinetics of 2,3,7,8-TCDD in man , 1986 .

[14]  S. Safe,et al.  Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. , 1986, Annual review of pharmacology and toxicology.

[15]  Y. Barrandon,et al.  Cell size as a determinant of the clone-forming ability of human keratinocytes. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Osborne,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) enhances terminal differentiation of cultured human epidermal cells. , 1985, Toxicology and applied pharmacology.

[17]  L. Hudson,et al.  Regulation of epidermal growth factor binding in a human keratinocyte cell line by 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1985, Toxicology and applied pharmacology.

[18]  S. Safe,et al.  In vitro AHH induction by polychlorinated biphenyl and dibenzofuran mixtures: Additive effects , 1985 .

[19]  J. Wendling,et al.  Background human exposure to 2,3,7,8-TCDD , 1985 .

[20]  L. Milstone,et al.  2,3,7,8-Tetrachlorodibenzo-p-dioxin induces hyperplasia in confluent cultures of human keratinocytes. , 1984, The Journal of investigative dermatology.

[21]  R. Rice,et al.  Opposing effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone on growth and differentiation of cultured malignant human keratinocytes. , 1984, Carcinogenesis.

[22]  L. Hudson,et al.  Induction of 7-ethoxycoumarin o-deethylase activity in cultured human epithelial cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): evidence for TCDD receptor. , 1983, Biochemical and biophysical research communications.

[23]  E. Lane,et al.  Effects of SV40 transformation on the cytoskeleton and behavioural properties of human keratinocytes. , 1982, Cell differentiation.

[24]  A Poland,et al.  2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. , 1982, Annual review of pharmacology and toxicology.

[25]  F. Watt,et al.  Involucrin synthesis is correlated with cell size in human epidermal cultures , 1981, The Journal of cell biology.

[26]  K. Crow.  Chloracne and its potential clinical implications , 1981, Clinical and experimental dermatology.

[27]  J. Rheinwald,et al.  Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas. , 1981, Cancer research.

[28]  J. Rheinwald,et al.  Defective terminal differentiation in culture as a consistent and selectable character of malignant human keratinocytes , 1980, Cell.

[29]  J. Rheinwald.  Chapter 15 Serial Cultivation of Normal Human Epidermal Keratinocytes , 1980 .

[30]  H. Green.  The keratinocyte as differentiated cell type. , 1980, Harvey lectures.

[31]  J. S. Taylor,et al.  Chloracne from manufacture of a new herbicide. , 1977, Archives of dermatology.

[32]  H. Green,et al.  Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell is , 1975, Cell.